Related Experiment Video
Updated: Mar 16, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Birt-Hogg-Dubé Syndrome.
Nishant Gupta1, Bernie Y Sunwoo2, Robert M Kotloff3
1Division of Pulmonary, Critical Care and Sleep Medicine, University of Cincinnati, 231 Albert Sabin Way, MSB Room 6053, ML 0564, Cincinnati, OH 45267, USA.
Birt-Hogg-Dubé syndrome (BHD) is a rare genetic disorder affecting skin, kidneys, and lungs. Research aims to clarify the unclear pathogenesis of tumor and lung cyst formation in BHD patients.
Area of Science:
- Genetics and rare diseases
- Oncology
- Pulmonology
Background:
- Birt-Hogg-Dubé syndrome (BHD) is an autosomal dominant disorder.
- It is caused by mutations in the Folliculin (FLCN) gene.
- BHD is associated with fibrofolliculomas, renal tumors, and lung cysts.
Purpose of the Study:
- To elucidate the pathogenesis of tumor and lung cyst formation in BHD.
- To understand the phenotypic variability in BHD patients.
- To highlight the prevalence of pulmonary findings in BHD.
Main Methods:
- Review of clinical and genetic data from BHD patients.
- Analysis of high-resolution computed tomography (HRCT) scans.
- Literature review on BHD pathogenesis.
Main Results:
- BHD presents with a variable combination of skin, renal, and pulmonary manifestations.
- Renal cancers and spontaneous pneumothoraces are key features.
- Over 80% of adult BHD patients exhibit pulmonary cysts on HRCT.
Conclusions:
- The pathogenesis of BHD-related tumors and cysts requires further investigation.
- Early recognition of BHD is crucial due to its multisystemic nature.
- Pulmonary involvement is highly prevalent in adult BHD patients.
Related Concept Videos
Genetic Lingo
Pedigree Analysis
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Probability Laws
Pleiotropy

